• 1. Daily consumption of cranberry improves endothelial function in healthy adults: a double blind randomized controlled trial
  Christian Heiss,Geoffrey Istas,Rodrigo P. Feliciano,Timon Weber,Brian Wang,Claudia Favari,Pedro Mena,Daniele Del Rio,Ana Rodriguez-Mateos Food Funct. 2022 13 3812
• 2. Determination of phenolic acids in palm oil samples by HPLC-UV-AD using homemade flow cell
  Rafaela Silva Lamarca,Renato Camargo Matos,Maria Auxiliadora Costa Matos Anal. Methods 2018 10 4535
• 3. The synthesis of axially disubstituted silicon phthalocyanines, their quaternized derivatives and first inhibitory effect on human cytosolic carbonic anhydrase isozymes hCA I and II
  Tayfun Arslan,Zekeriya Biyiklioglu,Murat ?entürk RSC Adv. 2018 8 10172
• 4. Gracilaria edulis exhibit antiproliferative activity against human lung adenocarcinoma cell line A549 without causing adverse toxic effect in vitro and in vivo
  Ravi Sakthivel,Samuthirapandi Muniasamy,Govindaraju Archunan,Kasi Pandima Devi Food Funct. 2016 7 1155
• 5. Development of adsorptive (non-ionic) macroporous resins and their uses in the purification of pharmacologically-active natural products from plant sources
  Jing Li,Howard A. Chase Nat. Prod. Rep. 2010 27 1493

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Hydroxycinnamic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Hydroxycinnamic acids and derivatives Hydroxycinnamic acids
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Study of 2-Hydroxycinnamic Acid (CAS: 614-60-8) in Chemical Biology and Medicine

2-Hydroxycinnamic acid (CAS: 614-60-8), a derivative of cinnamic acid, has garnered significant attention in recent years due to its diverse biological activities and potential therapeutic applications. This compound, characterized by a phenolic hydroxyl group at the ortho position of the cinnamic acid backbone, exhibits unique chemical properties that make it a promising candidate for drug development and biomedical research. Recent studies have explored its roles in antioxidant, anti-inflammatory, and anticancer activities, shedding light on its molecular mechanisms and potential clinical applications.

One of the most notable advancements in the study of 2-hydroxycinnamic acid is its role in modulating oxidative stress. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 2-hydroxycinnamic acid effectively scavenges reactive oxygen species (ROS) and upregulates endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). These findings suggest its potential as a therapeutic agent for diseases associated with oxidative stress, including neurodegenerative disorders and cardiovascular diseases.

In addition to its antioxidant properties, 2-hydroxycinnamic acid has shown promising anti-inflammatory effects. Research published in Bioorganic & Medicinal Chemistry Letters in 2024 revealed that this compound inhibits the NF-κB signaling pathway, a key regulator of inflammatory responses. By suppressing the production of pro-inflammatory cytokines such as TNF-α and IL-6, 2-hydroxycinnamic acid may offer a novel approach to treating chronic inflammatory conditions like rheumatoid arthritis and inflammatory bowel disease.

The anticancer potential of 2-hydroxycinnamic acid has also been a focal point of recent investigations. A 2023 study in Molecular Cancer Therapeutics reported that this compound induces apoptosis in various cancer cell lines, including breast and colon cancer, by activating the intrinsic mitochondrial pathway. Furthermore, it was found to synergize with conventional chemotherapeutic agents, enhancing their efficacy while reducing side effects. These findings highlight its potential as an adjunct therapy in oncology.

From a chemical perspective, the structural versatility of 2-hydroxycinnamic acid allows for the synthesis of various derivatives with enhanced bioactivity. Recent work published in European Journal of Medicinal Chemistry (2024) explored the modification of its phenolic hydroxyl group to improve pharmacokinetic properties, such as solubility and bioavailability. These efforts have led to the development of novel analogs with improved therapeutic profiles, paving the way for future drug discovery.

In conclusion, the growing body of research on 2-hydroxycinnamic acid (CAS: 614-60-8) underscores its multifaceted biological activities and therapeutic potential. Its applications in combating oxidative stress, inflammation, and cancer, coupled with its chemical adaptability, make it a compelling subject for further investigation. Future studies should focus on translational research to bridge the gap between laboratory findings and clinical applications, ultimately unlocking its full potential in medicine.

• 614-86-8((2E)-3-(2,4-Dihydroxyphenyl)acrylic Acid)
• 113170-66-4(2-Propenoic acid, 3-(2-hydroxyphenyl)-, copper(2+) salt (2:1))
• 7733-57-5(3,5-Dimethyl-4-hydroxycinnamic Acid)
• 38489-67-7(3-(2,5-dihydroxyphenyl)prop-2-enoic acid)
• 54951-70-1(2-Propenoic acid, 3-(hydroxyphenyl)-, (Z)-)
• 583-17-5(3-(2-Hydroxyphenyl)acrylic acid)
• 495-79-4(2-hydroxy cinnamic acid)
• 38094-41-6(2-Propenoic acid, 3-(hydroxyphenyl)-, (2E)-)
• 89311-95-5(2-Propenoic acid, 3-(2-hydroxyphenyl)-, monopotassium salt)
• 636-01-1((2E)-3-(2,5-Dihydroxyphenyl)acrylic Acid)